Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to understand if a new type of radiology test called positron emission tomography (PET) with carbon 11 acetate will help us to understand which cancers produce more of a protein called fatty acid synthase (FAS).

Key facts

Study ID

NCT00139191

Run by

Dana-Farber Cancer Institute

People needed

20

Starts

2005-07-01

Expected to finish

2006-05-01

Last updated by the study team

2009-11-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Histologically documented prostate cancer
• Planned radical prostatectomy
• > 50% cores positive for prostate cancer from prostate biopsy or a palpable prostate nodule
• Older than 18 years of age

You may not qualify if…

• Inability to lay on a scanner for 60 minutes

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.